NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
Funding Opportunity PAR-22-135 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some succe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 8, 2022 Category: Research Source Type: funding
NEI Regenerative Medicine Clinical Trial Planning Grant (R34 - Clinical Trials Not Allowed)
Funding Opportunity PAR-22-070 from the NIH Guide for Grants and Contracts. The National Eye Institute (NEI) Audacious Goal Initiative (AGI) is an effort to push the boundaries of vision science and restore vision through regeneration of cells in the retina. AGI research specifically targets photoreceptors (PRCs) and retinal ganglion cells (RGCs) in the eye. Photoreceptors often called rods and cones are cells in the retina that, when stimulated by light, generate signals the brain perceives as images. The retinal ganglion cells carry these signals from the photoreceptors to the brain. Although there has been some succe...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2021 Category: Research Source Type: funding
NEI Audacious Goals Initiative: Translation-Enabling Models to Evaluate Survival and Integration of Regenerated Neurons in the Visual System (U24 Clinical Trials Not Allowed)
Funding Opportunity RFA-EY-17-003 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to stimulate development of translation-enabling models for evaluating survival and integration of regenerated photoreceptors (PRCs) and retinal ganglion cells (RGCs) in model systems that are closer to human visual anatomy, function and/or disease than current models. The development of these models, tools, devices, novel therapies and/or other resources is expected to provide a resource to vision researchers developing cell-replacement therapies for visual system diseases and disorders. This FOA seeks to develop ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 7, 2017 Category: Research Source Type: funding
NEI Audacious Goal Initiative: Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)
Funding Opportunity Number: RFA-EY-14-001 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.867Eligible Applicants State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities/Indian housing authoritiesNative American tribal organizations (other than Federally recognized tribal governments)Nonprofits having a 501(c)(3) s...
Source: Grants.gov - April 24, 2014 Category: Research Tags: Health Source Type: funding
NEI Audacious Goal Initiative: Addressing Technical Needs and Opportunities for Imaging the Visual System (U01)
Funding Opportunity RFA-EY-14-001 from the NIH Guide for Grants and Contracts. The NEI Audacious Goal Initiative (AGI) strategic planning process (see http://www.nei.nih.gov/audacious) selected the single audacious goal (AG) of regenerating neurons and neural connections in the eye and visual system. This AG speaks to two conditions, loss of photoreceptor cells (PRC) by disease or injury and damage to retinal ganglion cells (RGC) as occurs in glaucoma or optic neuropathy. The AGI process also identified two areas of high programmatic priority, developing new treatments for eye disease using molecular approaches and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - April 23, 2014 Category: Research Source Type: funding
